Corticosteroid vs PRP Injections for Shoulder Osteoarthritis
Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)
Recruiting
N/A
Interventional Study
Arthritis Shoulder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Rush University Medical Center · Other
Who this trial is looking for
This trial is looking for adults with diagnosed shoulder arthritis. Participants will receive either a corticosteroid or platelet-rich plasma injection to see which provides better pain relief.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old.
- I have been diagnosed with primary shoulder arthritis.
- My pain level is more than 4 on a scale of 10.
You may not be able to join if
- I have another type of arthritis.
- I have had shoulder surgery in the past year.
- I have received an injection in my shoulder in the past 3 months.
- I am allergic to lidocaine.
- I am pregnant.
- I have a workers compensation case related to my shoulder.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to compare the efficacy of intra-articular corticosteroid injections versus platelet-rich plasma injections for non-operative treatment of primary glenohumeral osteoarthritis. The efficacy of intra-articular injections, outside of hyaluronic acid, for the treatment of glenohumeral OA is not known, yet these treatments are commonly used with hopes of providing patients …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient ≥18y.o. of age
* Primary glenohumeral arthritis (bone on bone or near bone on bone) that has been previously diagnosed on radiographs and clinical evaluation.
* Baseline pain level of VAS \>4
Exclusion Criteria:
* Secondary causes of arthritis (i.e. septic arthritis,…
Contacts